nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—HSD17B1—The canonical retinoid cycle in rods (twilight vision)—HSD17B6—ovarian cancer	0.244	0.414	CbGpPWpGaD
Equilin—HSD17B1—female reproductive system—ovarian cancer	0.108	0.307	CbGeAlD
Equilin—HSD17B1—female gonad—ovarian cancer	0.0983	0.279	CbGeAlD
Equilin—HSD17B1—Diseases associated with visual transduction—HSD17B6—ovarian cancer	0.0758	0.129	CbGpPWpGaD
Equilin—SHBG—endometrium—ovarian cancer	0.022	0.0624	CbGeAlD
Equilin—SHBG—gonad—ovarian cancer	0.0204	0.0579	CbGeAlD
Equilin—SHBG—uterus—ovarian cancer	0.0203	0.0575	CbGeAlD
Equilin—SHBG—female reproductive system—ovarian cancer	0.0182	0.0517	CbGeAlD
Equilin—SHBG—bone marrow—ovarian cancer	0.0172	0.0488	CbGeAlD
Equilin—SHBG—female gonad—ovarian cancer	0.0166	0.0471	CbGeAlD
Equilin—SHBG—vagina—ovarian cancer	0.0165	0.0468	CbGeAlD
Equilin—SHBG—testis—ovarian cancer	0.0147	0.0417	CbGeAlD
Equilin—SHBG—Nongenotropic Androgen signaling—MAPK3—ovarian cancer	0.0116	0.0197	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—MAPK1—ovarian cancer	0.0111	0.0187	CbGpPWpGaD
Equilin—HSD17B1—Disease—HSD17B6—ovarian cancer	0.00962	0.0163	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—PIK3CA—ovarian cancer	0.00959	0.0163	CbGpPWpGaD
Equilin—Estriol—ESR1—ovarian cancer	0.00957	0.165	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00932	0.0158	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—HRAS—ovarian cancer	0.00888	0.0151	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—AKT1—ovarian cancer	0.00784	0.0133	CbGpPWpGaD
Equilin—HSD17B1—Disease—CHMP4C—ovarian cancer	0.00769	0.013	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NME2—ovarian cancer	0.00737	0.0125	CbGpPWpGaD
Equilin—Estropipate—ESR1—ovarian cancer	0.00732	0.126	CrCbGaD
Equilin—Estrone—CYP1B1—ovarian cancer	0.00674	0.116	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—HSD17B6—ovarian cancer	0.00674	0.0114	CbGpPWpGaD
Equilin—HSD17B1—Disease—BCL9—ovarian cancer	0.00667	0.0113	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00625	0.0106	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DLC1—ovarian cancer	0.00573	0.00972	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ESR1—ovarian cancer	0.00523	0.0899	CrCbGaD
Equilin—Estradiol—CYP1B1—ovarian cancer	0.00511	0.0878	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.0051	0.00864	CbGpPWpGaD
Equilin—HSD17B1—Disease—PPP1CC—ovarian cancer	0.00496	0.00841	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYTB—ovarian cancer	0.00475	0.00806	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BCL9—ovarian cancer	0.00467	0.00792	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.00464	0.00787	CbGpPWpGaD
Equilin—Conjugated Estrogens—ESR1—ovarian cancer	0.00457	0.0785	CrCbGaD
Equilin—Estrone—ESR1—ovarian cancer	0.00456	0.0783	CrCbGaD
Equilin—HSD17B1—Metabolism—PPP1CC—ovarian cancer	0.00415	0.00704	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—BRIP1—ovarian cancer	0.00415	0.00704	CbGpPWpGaD
Equilin—Estriol—ABCB1—ovarian cancer	0.00407	0.0699	CrCbGaD
Equilin—HSD17B1—Disease—HDAC6—ovarian cancer	0.00376	0.00637	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DOK1—ovarian cancer	0.00369	0.00626	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PPP1CC—ovarian cancer	0.00347	0.00589	CbGpPWpGaD
Equilin—Estradiol—ESR1—ovarian cancer	0.00345	0.0593	CrCbGaD
Equilin—HSD17B1—Disease—XIAP—ovarian cancer	0.00326	0.00552	CbGpPWpGaD
Equilin—HSD17B1—Disease—SMARCA4—ovarian cancer	0.00317	0.00538	CbGpPWpGaD
Equilin—HSD17B1—Disease—EREG—ovarian cancer	0.0031	0.00525	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.00303	0.00513	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—YAP1—ovarian cancer	0.00279	0.00472	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.00276	0.00467	CbGpPWpGaD
Equilin—HSD17B1—Disease—FASN—ovarian cancer	0.00271	0.0046	CbGpPWpGaD
Equilin—HSD17B1—Disease—PARP1—ovarian cancer	0.0027	0.00458	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HDAC6—ovarian cancer	0.00263	0.00446	CbGpPWpGaD
Equilin—HSD17B1—Disease—SLC2A1—ovarian cancer	0.00258	0.00437	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.00242	0.00411	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—YAP1—ovarian cancer	0.00233	0.00395	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—XIAP—ovarian cancer	0.00228	0.00387	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—FASN—ovarian cancer	0.00227	0.00385	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC5A5—ovarian cancer	0.00223	0.00379	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SMARCA4—ovarian cancer	0.00222	0.00377	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ABCB1—ovarian cancer	0.00222	0.0382	CrCbGaD
Equilin—HSD17B1—Disease—PPP2R1A—ovarian cancer	0.00219	0.00371	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EREG—ovarian cancer	0.00217	0.00368	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC2A1—ovarian cancer	0.00216	0.00366	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.00211	0.00358	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP1B1—ovarian cancer	0.00207	0.00351	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PGR—ovarian cancer	0.00203	0.00345	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCB1—ovarian cancer	0.00194	0.0334	CrCbGaD
Equilin—Estrone—ABCB1—ovarian cancer	0.00194	0.0333	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—PARP1—ovarian cancer	0.00189	0.00321	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPP2R1A—ovarian cancer	0.00183	0.00311	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.00182	0.00309	CbGpPWpGaD
Equilin—HSD17B1—Disease—TERT—ovarian cancer	0.00174	0.00295	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCB1—ovarian cancer	0.0017	0.00289	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TYMS—ovarian cancer	0.00167	0.00284	CbGpPWpGaD
Equilin—HSD17B1—Disease—CAV1—ovarian cancer	0.00161	0.00273	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PPP2R1A—ovarian cancer	0.00153	0.0026	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6ST—ovarian cancer	0.00153	0.00259	CbGpPWpGaD
Equilin—Estradiol—ABCB1—ovarian cancer	0.00147	0.0252	CrCbGaD
Equilin—HSD17B1—Disease—APC—ovarian cancer	0.00147	0.00249	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CAV1—ovarian cancer	0.00135	0.00229	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CD—ovarian cancer	0.00129	0.00218	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.00129	0.00218	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CG—ovarian cancer	0.00123	0.00208	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TERT—ovarian cancer	0.00122	0.00207	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB2—ovarian cancer	0.00114	0.00193	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CAV1—ovarian cancer	0.00113	0.00191	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTOR—ovarian cancer	0.00112	0.0019	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CB—ovarian cancer	0.00112	0.0019	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ESR1—ovarian cancer	0.00109	0.00184	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CD—ovarian cancer	0.00108	0.00183	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6ST—ovarian cancer	0.00107	0.00181	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN1B—ovarian cancer	0.00105	0.00179	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CG—ovarian cancer	0.00103	0.00174	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APC—ovarian cancer	0.00103	0.00174	CbGpPWpGaD
Equilin—HSD17B1—Disease—CTNNB1—ovarian cancer	0.000996	0.00169	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTEN—ovarian cancer	0.00097	0.00165	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CB—ovarian cancer	0.000941	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CD—ovarian cancer	0.000902	0.00153	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT3—ovarian cancer	0.000868	0.00147	CbGpPWpGaD
Equilin—HSD17B1—Disease—NRAS—ovarian cancer	0.000866	0.00147	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAPK3—ovarian cancer	0.000829	0.00141	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTEN—ovarian cancer	0.000813	0.00138	CbGpPWpGaD
Equilin—HSD17B1—Disease—MYC—ovarian cancer	0.000806	0.00137	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB2—ovarian cancer	0.000797	0.00135	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAPK1—ovarian cancer	0.000789	0.00134	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGFR—ovarian cancer	0.000789	0.00134	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CB—ovarian cancer	0.000786	0.00133	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MTOR—ovarian cancer	0.000786	0.00133	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL8—ovarian cancer	0.000756	0.00128	CbGpPWpGaD
Equilin—HSD17B1—Disease—KRAS—ovarian cancer	0.000745	0.00126	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN1B—ovarian cancer	0.000738	0.00125	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—ovarian cancer	0.000723	0.00123	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL2—ovarian cancer	0.000722	0.00122	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCND1—ovarian cancer	0.000704	0.00119	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CTNNB1—ovarian cancer	0.000697	0.00118	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CA—ovarian cancer	0.000685	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP9—ovarian cancer	0.000684	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTEN—ovarian cancer	0.00068	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Disease—HRAS—ovarian cancer	0.000633	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—ovarian cancer	0.000614	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT3—ovarian cancer	0.000608	0.00103	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NRAS—ovarian cancer	0.000606	0.00103	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—ovarian cancer	0.000606	0.00103	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK3—ovarian cancer	0.000581	0.000985	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CA—ovarian cancer	0.000573	0.000972	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MYC—ovarian cancer	0.000565	0.000958	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—ovarian cancer	0.000559	0.000948	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK1—ovarian cancer	0.000552	0.000937	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGFR—ovarian cancer	0.000552	0.000937	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KRAS—ovarian cancer	0.000522	0.000885	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CA—ovarian cancer	0.000479	0.000813	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—ovarian cancer	0.000468	0.000794	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—ovarian cancer	0.000464	0.000786	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HRAS—ovarian cancer	0.000444	0.000752	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—ovarian cancer	0.000425	0.00072	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—ovarian cancer	0.000392	0.000664	CbGpPWpGaD
